Skip to content

Clinical trials

Completed Phase 3 Epilepsy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsy Phase: Phase 3 Status: Completed Clear all

182 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20025
20034
200413
200511
200616
200714
200811
20093
201016
201114
20127
201310
20147
201511
20166
20175
20185
20193
20202
20211
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed182

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UCB Pharma23
GlaxoSmithKline15
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.11
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.10
Eisai Inc.9
UCB Pharma SA9
Bial - Portela C S.A.8
UCB BIOSCIENCES, Inc.8
UCB Japan Co. Ltd.8
UCB Biopharma SRL5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsy182
Seizures74
Epilepsies, Partial31
Lennox Gastaut Syndrome9
Epilepsies, Myoclonic6
Epilepsy, Complex Partial6
Epilepsy, Tonic-Clonic6
Epilepsy, Generalized5
Migraine Disorders5
Brain Diseases4

Trials

Showing 1 to 25 of 182. Each trial links to its page on Pharma Observatory.

82 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.